It has been reported that S100A8 upregulated PD-L1 in macrophages via a TLR4-dependent pathway [29], and we previously found that the inhibition of TLR4 by Eritoran increased intratumoral infiltration of CD8+ cells in LLC-tumor-bearing mice [8]. The gene discussed is CD8A; the disease is neoplasm.